Roy D. Baynes, Director: Travere Therapeutics TVTX Planned sale · Filed 06/12

Trade details

Type: Planned sale notice
Stock: Travere Therapeutics TVTX
Person: Roy D. BaynesDirector
Planned sale date: 26/06/12
Filed: 26/06/12

More to sell after $2.3M in 3 months

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 05/13~07/12

Roy D. Baynes's recent trades

Roy D. BaynesDirector
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$225K
4,500 sh
$225K
Filed 06/16
Traded 06/12
Roy D. BaynesDirector
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$209.9K
4,500 sh
$209.9K
Filed 05/06
Traded 05/05
Roy D. BaynesDirector
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$209.9K
4,500 sh
$209.9K
Filed 05/05
Traded 05/05
Roy D. BaynesDirector
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$431.1K
9,750 sh
$431.1K
Filed 05/04
Traded 05/01
Roy D. BaynesDirector
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$431.1K
9,750 sh
$431.1K
Filed 05/01
Traded 05/01

Roy D. Baynes, Director — plans to sell 4,500 sh of Travere Therapeutics TVTX · $225K · around 06/12 · 10b5-1 plan | Whalegun